-
1
-
-
0030013538
-
Appraisal of effectiveness and potential therapeutic benefit of acarbose: a non-consensus conference (workshop report)
-
M Berger J Kobberling J Windeler Appraisal of effectiveness and potential therapeutic benefit of acarbose: a non-consensus conference (workshop report) Diabetologia 39 1996 873 874
-
(1996)
Diabetologia
, vol.39
, pp. 873-874
-
-
Berger, M1
Kobberling, J2
Windeler, J3
-
3
-
-
0028964635
-
Measurement of proinsulin and intermediates: validation of immunoassay methods by high performance liquid chromatography
-
D Ostrega K Polonsky D Nagi Measurement of proinsulin and intermediates: validation of immunoassay methods by high performance liquid chromatography Diabetes 44 1995 437 440
-
(1995)
Diabetes
, vol.44
, pp. 437-440
-
-
Ostrega, D1
Polonsky, K2
Nagi, D3
-
4
-
-
0028224821
-
New pharmacological approaches to insulin and lipid metabolism
-
JR Petrie R Donnelly New pharmacological approaches to insulin and lipid metabolism Drugs 47 1994 701 710
-
(1994)
Drugs
, vol.47
, pp. 701-710
-
-
Petrie, JR1
Donnelly, R2
-
5
-
-
0027983920
-
Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
-
JJ Nolan B Ludvik P Beerdsen Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone N Engl J Med 331 1994 1188 1193
-
(1994)
N Engl J Med
, vol.331
, pp. 1188-1193
-
-
Nolan, JJ1
Ludvik, B2
Beerdsen, P3
-
6
-
-
0030012267
-
Effect of combination therapy of troglitazone and sulphonylureas in patients with type 2 diabetes who were poorly controlled by sulphonylurea therapy alone
-
Y Iwamoto K Kosaka T Kuzuya Effect of combination therapy of troglitazone and sulphonylureas in patients with type 2 diabetes who were poorly controlled by sulphonylurea therapy alone Diabetic Med 13 1996 365 370
-
(1996)
Diabetic Med
, vol.13
, pp. 365-370
-
-
Iwamoto, Y1
Kosaka, K2
Kuzuya, T3
-
7
-
-
0025053123
-
Actions of novel antidiabetic agent englitazone in hyperglycaemic ob/ob mice
-
RW Stevenson NJ Hutson MN Krupp Actions of novel antidiabetic agent englitazone in hyperglycaemic ob/ob mice Diabetes 39 1990 1218 1227
-
(1990)
Diabetes
, vol.39
, pp. 1218-1227
-
-
Stevenson, RW1
Hutson, NJ2
Krupp, MN3
-
8
-
-
0029119082
-
Fibrates increase human apolipoprotein AII expression through activation of the peroxisome proliferator-activated receptor
-
N Vu-Dac K Schoonjans V Kosykh Fibrates increase human apolipoprotein AII expression through activation of the peroxisome proliferator-activated receptor J Clin Invest 96 1995 741 750
-
(1995)
J Clin Invest
, vol.96
, pp. 741-750
-
-
Vu-Dac, N1
Schoonjans, K2
Kosykh, V3
-
9
-
-
0030602866
-
The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and cell differentiation
-
K Schoonjans B Staels J Auwerx The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and cell differentiation Biochim Biophys Acta 1302 1996 93 109
-
(1996)
Biochim Biophys Acta
, vol.1302
, pp. 93-109
-
-
Schoonjans, K1
Staels, B2
Auwerx, J3
-
10
-
-
0028584172
-
Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells
-
A Ibrahimi L Teboul D Gaillard Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells Mol Pharmacol 46 1994 1070 1076
-
(1994)
Mol Pharmacol
, vol.46
, pp. 1070-1076
-
-
Ibrahimi, A1
Teboul, L2
Gaillard, D3
|